We believe there is 80% downside to Predictive’s shares purely on valuation alone and 95%+ downside given the issues we have uncovered.

The Company’s lack of response just furthers our suspicions. Any time a company fails to address the facts lodged against it on a point by point basis it suggests, to us, that the facts are not on its side. We believe it is of utmost importance to note what management has not said with today’s non-response. This is just a partial list of our findings, but should be an obvious starting point on items that shareholders deserve to know:

We think this COVID-19 rapid testing stunt is the company’s last attempt at salvaging itself, as Predictive’s financials suggest to us that the company is months, if not weeks, away from insolvency. We see 100% near-term downside in shares of Predictive and expect that Predictive must continue to dilute equity through near-term stock sales in order to survive.